title: The canine papillomavirus and gamma HPV E7 proteins use an alternative domain to bind and destabilize the retinoblastoma protein.
abstract: The high-risk HPV E6 and E7 proteins cooperate to immortalize primary human cervical cells and the E7 protein can independently transform fibroblasts in vitro, primarily due to its ability to associate with and degrade the retinoblastoma tumor suppressor protein, pRb. The binding of E7 to pRb is mediated by a conserved Leu-X-Cys-X-Glu (LXCXE) motif in the conserved region 2 (CR2) of E7 and this domain is both necessary and sufficient for E7/pRb association. In the current study, we report that the E7 protein of the malignancy-associated canine papillomavirus type 2 encodes an E7 protein that has serine substituted for cysteine in the LXCXE motif. In HPV, this substitution in E7 abrogates pRb binding and degradation. However, despite variation at this critical site, the canine papillomavirus E7 protein still bound and degraded pRb. Even complete deletion of the LXSXE domain of canine E7 failed to interfere with binding to pRb in vitro and in vivo. Rather, the dominant binding site for pRb mapped to the C-terminal domain of canine E7. Finally, while the CR1 and CR2 domains of HPV E7 are sufficient for degradation of pRb, the C-terminal region of canine E7 was also required for pRb degradation. Screening of HPV genome sequences revealed that the LXSXE motif of the canine E7 protein was also present in the gamma HPVs and we demonstrate that the gamma HPV-4 E7 protein also binds pRb in a similar way. It appears, therefore, that the type 2 canine PV and gamma-type HPVs not only share similar properties with respect to tissue specificity and association with immunosuppression, but also the mechanism by which their E7 proteins interact with pRb.
authors.affiliation: Department of Pathology, Georgetown University Medical School, Washington, D.C., USA.
authors.forename: Jingang
authors.initials: J
authors.lastname: Wang
authors.forename: Dan
authors.initials: D
authors.lastname: Zhou
authors.forename: Anjali
authors.initials: A
authors.lastname: Prabhu
authors.forename: Richard
authors.initials: R
authors.lastname: Schlegel
authors.forename: Hang
authors.initials: H
authors.lastname: Yuan
mesh_terms: D020816:Amino Acid Motifs; D000595:Amino Acid Sequence; D000818:Animals; D001665:Binding Sites; D015153:Blotting, Western; D001859:Bone Neoplasms / Q000378:metabolism / Q000473:pathology; D004285:Dogs; D006801:Humans; D051379:Mice; D008969:Molecular Sequence Data; D012516:Osteosarcoma / Q000378:metabolism / Q000473:pathology; D027383:Papillomaviridae / Q000502:physiology*; D050725:Papillomavirus E7 Proteins / Q000235:genetics / Q000378:metabolism*; D030361:Papillomavirus Infections / Q000378:metabolism* / Q000473:pathology / Q000821:virology; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D012333:RNA, Messenger / Q000235:genetics; D016160:Retinoblastoma Protein / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D017386:Sequence Homology, Amino Acid; D014407:Tumor Cells, Cultured
chemical_list: D050725:Papillomavirus E7 Proteins; D012333:RNA, Messenger; D016160:Retinoblastoma Protein; C059731:oncogene protein E7, Human papillomavirus type 16
references.citation: Virology. 1996 Mar 15;217(2):542-53
references.pmid: 8610446
references.citation: J Virol. 2006 Jul;80(13):6621-8
references.pmid: 16775349
references.citation: Oncogene. 2006 Aug 28;25(38):5277-85
references.pmid: 16936748
references.citation: J Virol. 1992 Apr;66(4):2418-27
references.pmid: 1312637
references.citation: Virology. 2007 Mar 1;359(1):28-36
references.pmid: 17034826
references.citation: J Virol. 2002 Nov;76(21):10685-91
references.pmid: 12368310
references.citation: Mol Cell Biol. 1993 Feb;13(2):953-60
references.pmid: 7678696
references.citation: Virology. 2009 Feb 20;384(2):335-44
references.pmid: 19007963
references.citation: J Virol. 2001 Sep;75(17):7848-53
references.pmid: 11483728
references.citation: J Virol. 1994 Sep;68(9):6120-3
references.pmid: 8057494
references.citation: Virology. 1995 Dec 1;214(1):289-93
references.pmid: 8525630
references.citation: J Virol. 1984 Sep;51(3):872-5
references.pmid: 6088809
references.citation: J Virol. 1993 Apr;67(4):2402-7
references.pmid: 8445736
references.citation: Cancer Res. 2005 Dec 1;65(23):10854-61
references.pmid: 16322232
references.citation: J Virol. 1989 Jun;63(6):2650-6
references.pmid: 2542578
references.citation: J Gen Virol. 2009 Nov;90(Pt 11):2615-2621
references.pmid: 19656968
references.citation: J Biol Chem. 1994 Mar 4;269(9):6842-50
references.pmid: 8120046
references.citation: J Gen Virol. 1999 Feb;80 ( Pt 2):327-332
references.pmid: 10073691
references.citation: Cancer Detect Prev. 2008;32(1):15-22
references.pmid: 18406069
references.citation: EMBO J. 1989 Dec 20;8(13):4099-105
references.pmid: 2556261
references.citation: Virology. 2004 Jun 20;324(1):17-27
references.pmid: 15183049
references.citation: Int J Biochem Cell Biol. 2007;39(11):2006-11
references.pmid: 17768080
references.citation: Vaccine. 2001 Apr 6;19(20-22):2783-92
references.pmid: 11282188
references.citation: J Virol. 2001 Aug;75(15):6737-47
references.pmid: 11435552
references.citation: EMBO J. 1999 May 4;18(9):2449-58
references.pmid: 10228159
references.citation: J Biol Chem. 2006 Jan 6;281(1):578-86
references.pmid: 16249186
references.citation: J Virol. 2004 Nov;78(22):12698-702
references.pmid: 15507660
references.citation: Mol Biol Evol. 2007 Aug;24(8):1596-9
references.pmid: 17488738
references.citation: J Virol. 2007 Sep;81(18):9737-47
references.pmid: 17609271
references.citation: Nat Rev Cancer. 2007 Jan;7(1):11-22
references.pmid: 17186016
references.citation: J Virol. 1992 Dec;66(12):6893-902
references.pmid: 1331501
references.citation: Virology. 2009 Feb 20;384(2):324-34
references.pmid: 19081593
references.citation: EMBO J. 1988 Oct;7(10):3181-7
references.pmid: 2460337
references.citation: Nat Rev Cancer. 2002 May;2(5):342-50
references.pmid: 12044010
references.citation: J Biol Chem. 1990 Aug 5;265(22):12782-5
references.pmid: 2198278
references.citation: J Virol. 2004 Nov;78(21):11451-60
references.pmid: 15479788
references.citation: J Gen Virol. 1990 Apr;71 ( Pt 4):965-70
references.pmid: 2157805
references.citation: J Virol. 1988 May;62(5):1814-8
references.pmid: 2965766
references.citation: J Virol. 1992 Mar;66(3):1329-35
references.pmid: 1310752
references.citation: Nucleic Acids Res. 1994 Nov 11;22(22):4673-80
references.pmid: 7984417
references.citation: Oncogene. 2001 Nov 26;20(54):7888-98
references.pmid: 11753671